The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis

    NEXT STORY
    GigaGen to Present at the Inaugural LifeSci Partners Private Company Virtual Summer Symposium
    PREV STORY
    Smile Direct Club Now Serving Orthodontia’s Largest and Fastest-Growing Segment: Teens
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Diffusion Pharmaceuticals Announces Pre-IND Submission to the FDA of Design for TSC Trials to Treat Acute Respiratory Distress Syndrome in COVID-19

    author_avatar
    NASDAQ Market News

    Blood and Blood Components Market worth over $43.5 Billion by 2024: Global Market Insights, Inc.

    U.S. blood and blood components market accounted for over 90% of North American industry ...

    author_avatar
    NASDAQ Market News

    Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab

    -  Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic ...

    author_avatar
    NASDAQ Market News